Monarch Diagnostics announced the opening of its newest full-service clinical laboratory in Dallas, Texas. Launching in fall 2025, this expansion marks the company’s first facility outside of California and reflects its ongoing commitment to improving healthcare outcomes through faster, more accessible lab services. By establishing a presence in North Texas, Monarch aims to provide local healthcare providers, behavioral health programs, and addiction treatment centers with reliable testing solutions and dedicated regional support.

Health Technology Insights: Merck, Eisai Update Phase 3 LEAP-012 Liver Cancer Trial

Our expansion into Dallas advances our mission to make fast, accurate toxicology testing more accessible. We’re proud to bring our services to Texas and support the providers who are on the front lines of addiction recovery and behavioral healthcare.

The Dallas lab offers several advantages to local facilities, including:

  • Same-day (12-hour) toxicology screenings and next-day (24-hour) confirmations
  • Regional courier pickups to support same-day lab intake and dependable turnaround times
  • Capacity to support high-volume, fast-paced treatment environments
  • Dedicated account managers for streamlined communication and support

Health Technology Insights: Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

“Our expansion into Dallas advances our mission to make fast, accurate toxicology testing more accessible,” said Michael Blaksley, CEO of Monarch Diagnostics. “We’re proud to bring our services to Texas and support the providers who are on the front lines of addiction recovery and behavioral healthcare.”

What sets Monarch apart:

  • Specialization in toxicology and medication monitoring tailored to behavioral health
  • Custom test panels designed to meet the specific needs of each facility
  • Clinical consultants available to help interpret complex lab findings
  • A concierge-style service model with mobile collection and one-on-one account management

Health Technology Insights: Ares Direct Lending Raises $1.5 Billion for Specialty Healthcare Strategy

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com

Source- businesswire